InsiderTrades

Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.

Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-28 · accession 0001062822-26-000037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-03 2026-02-28 LXRX DeFrancesco Lisa SVP, IR, Corp Comm F - Tax $1.47 -74.6K 93.9K -44% -$109.6K
DM 2026-03-03 2026-02-28 LXRX DeFrancesco Lisa SVP, IR, Corp Comm M - OptEx — +152.9K 40.3K New —
DM 2026-03-03 2026-02-28 LXRX DeFrancesco Lisa SVP, IR, Corp Comm M - OptEx — -152.9K 256.4K -37% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-28 F D 74,572 $1.47 93,869 D — —
2 Common Common Stock 2026-02-28 M A 128,190 — 168,441 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock.
3 Common Common Stock 2026-02-28 M A 24,674 — 40,251 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock.
4 Derivative Restricted Stock Units 2026-02-28 M D 24,674 — 24,673 D — · — to — 24,674 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. (F4) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
5 Derivative Restricted Stock Units 2026-02-28 M D 128,190 — 256,380 D — · — to — 128,190 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F4) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.